SLTM | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	40 studies	29% ± 11%	Explore
B cell	36 studies	28% ± 7%	Explore
natural killer cell	35 studies	30% ± 8%	Explore
fibroblast	31 studies	25% ± 8%	Explore
CD4-positive, alpha-beta T cell	31 studies	24% ± 7%	Explore
CD8-positive, alpha-beta T cell	31 studies	26% ± 7%	Explore
macrophage	29 studies	26% ± 10%	Explore
T cell	28 studies	26% ± 7%	Explore
pericyte	26 studies	22% ± 7%	Explore
smooth muscle cell	24 studies	22% ± 4%	Explore
regulatory T cell	23 studies	28% ± 6%	Explore
classical monocyte	22 studies	26% ± 11%	Explore
memory B cell	19 studies	27% ± 6%	Explore
ciliated cell	19 studies	34% ± 12%	Explore
naive B cell	19 studies	26% ± 6%	Explore
conventional dendritic cell	18 studies	27% ± 16%	Explore
non-classical monocyte	18 studies	28% ± 11%	Explore
mast cell	17 studies	24% ± 8%	Explore
gamma-delta T cell	17 studies	30% ± 12%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	16 studies	25% ± 8%	Explore
mature NK T cell	16 studies	26% ± 6%	Explore
monocyte	15 studies	27% ± 10%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	33% ± 8%	Explore
basal cell	15 studies	32% ± 16%	Explore
epithelial cell	15 studies	34% ± 22%	Explore
CD16-negative, CD56-bright natural killer cell, human	15 studies	31% ± 7%	Explore
plasmacytoid dendritic cell	14 studies	32% ± 10%	Explore
astrocyte	14 studies	30% ± 15%	Explore
mucosal invariant T cell	14 studies	26% ± 5%	Explore
endothelial cell of lymphatic vessel	13 studies	28% ± 6%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	13 studies	27% ± 8%	Explore
oligodendrocyte	13 studies	34% ± 15%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	31% ± 9%	Explore
capillary endothelial cell	12 studies	20% ± 4%	Explore
microglial cell	12 studies	32% ± 12%	Explore
CD4-positive, alpha-beta memory T cell	11 studies	26% ± 7%	Explore
myofibroblast cell	11 studies	24% ± 4%	Explore
connective tissue cell	11 studies	22% ± 6%	Explore
oligodendrocyte precursor cell	11 studies	31% ± 13%	Explore
type I pneumocyte	10 studies	31% ± 6%	Explore
club cell	10 studies	26% ± 10%	Explore
effector memory CD8-positive, alpha-beta T cell	10 studies	31% ± 9%	Explore
vein endothelial cell	10 studies	21% ± 7%	Explore
dendritic cell	10 studies	39% ± 22%	Explore
myeloid cell	10 studies	34% ± 10%	Explore
type II pneumocyte	9 studies	29% ± 9%	Explore
plasma cell	9 studies	27% ± 11%	Explore
adipocyte	9 studies	57% ± 16%	Explore
endothelial cell of vascular tree	9 studies	23% ± 7%	Explore
respiratory goblet cell	8 studies	31% ± 11%	Explore
GABAergic neuron	8 studies	35% ± 20%	Explore
abnormal cell	8 studies	27% ± 9%	Explore
endothelial cell of artery	8 studies	22% ± 3%	Explore
amacrine cell	8 studies	28% ± 13%	Explore
retinal rod cell	8 studies	31% ± 9%	Explore
plasmablast	7 studies	46% ± 22%	Explore
secretory cell	7 studies	31% ± 13%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	28% ± 8%	Explore
leukocyte	7 studies	30% ± 7%	Explore
neuron	7 studies	37% ± 16%	Explore
glutamatergic neuron	7 studies	43% ± 24%	Explore
precursor B cell	7 studies	38% ± 10%	Explore
retinal cone cell	7 studies	39% ± 13%	Explore
T follicular helper cell	7 studies	25% ± 4%	Explore
hematopoietic precursor cell	6 studies	37% ± 14%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	26% ± 7%	Explore
kidney loop of Henle epithelial cell	6 studies	18% ± 2%	Explore
lymphocyte	6 studies	33% ± 12%	Explore
retina horizontal cell	6 studies	30% ± 10%	Explore
Mueller cell	6 studies	24% ± 5%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	29% ± 9%	Explore
innate lymphoid cell	6 studies	30% ± 7%	Explore
mononuclear phagocyte	5 studies	28% ± 9%	Explore
progenitor cell	5 studies	23% ± 6%	Explore
interneuron	5 studies	38% ± 21%	Explore
hematopoietic stem cell	5 studies	32% ± 10%	Explore
pro-B cell	5 studies	34% ± 8%	Explore
cardiac muscle cell	5 studies	31% ± 4%	Explore
mesothelial cell	5 studies	22% ± 8%	Explore
goblet cell	5 studies	36% ± 22%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	24% ± 4%	Explore
deuterosomal cell	4 studies	24% ± 7%	Explore
squamous epithelial cell	4 studies	34% ± 22%	Explore
pancreatic A cell	4 studies	44% ± 13%	Explore
exhausted T cell	4 studies	35% ± 11%	Explore
kidney distal convoluted tubule epithelial cell	4 studies	25% ± 6%	Explore
retinal bipolar neuron	4 studies	32% ± 11%	Explore
glial cell	4 studies	26% ± 11%	Explore
brush cell	4 studies	27% ± 8%	Explore
immature B cell	4 studies	30% ± 6%	Explore
retinal pigment epithelial cell	4 studies	34% ± 14%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	28% ± 8%	Explore
hepatocyte	4 studies	43% ± 16%	Explore
alveolar macrophage	4 studies	35% ± 12%	Explore
transit amplifying cell	4 studies	36% ± 31%	Explore
T-helper 17 cell	4 studies	25% ± 3%	Explore
ionocyte	3 studies	31% ± 4%	Explore
type B pancreatic cell	3 studies	45% ± 14%	Explore
glomerular endothelial cell	3 studies	21% ± 4%	Explore
renal alpha-intercalated cell	3 studies	19% ± 2%	Explore
neural crest cell	3 studies	26% ± 1%	Explore
extravillous trophoblast	3 studies	34% ± 19%	Explore
GABAergic amacrine cell	3 studies	22% ± 4%	Explore
OFF-bipolar cell	3 studies	24% ± 6%	Explore
ON-bipolar cell	3 studies	23% ± 5%	Explore
glycinergic amacrine cell	3 studies	24% ± 3%	Explore
rod bipolar cell	3 studies	34% ± 4%	Explore
erythroblast	3 studies	45% ± 19%	Explore
germinal center B cell	3 studies	32% ± 2%	Explore
CD4-positive helper T cell	3 studies	31% ± 9%	Explore
muscle cell	3 studies	32% ± 16%	Explore
pancreatic ductal cell	3 studies	43% ± 16%	Explore
granulocyte	3 studies	26% ± 7%	Explore
enteroendocrine cell	3 studies	28% ± 12%	Explore
adventitial cell	3 studies	23% ± 3%	Explore
erythrocyte	3 studies	32% ± 17%	Explore
group 3 innate lymphoid cell	3 studies	45% ± 10%	Explore
keratinocyte	3 studies	22% ± 6%	Explore
granule cell	3 studies	25% ± 6%	Explore
T-helper 1 cell	3 studies	26% ± 2%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	24% ± 3%	Explore
central memory CD8-positive, alpha-beta T cell	3 studies	23% ± 3%	Explore
double negative thymocyte	3 studies	42% ± 16%	Explore
myoepithelial cell	3 studies	23% ± 3%	Explore
mucus secreting cell	3 studies	26% ± 2%	Explore
renal principal cell	3 studies	21% ± 2%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	17 studies	28% ± 9%	Explore
peripheral blood	16 studies	29% ± 11%	Explore
brain	16 studies	33% ± 18%	Explore
eye	10 studies	30% ± 11%	Explore
kidney	8 studies	21% ± 5%	Explore
intestine	8 studies	21% ± 8%	Explore
heart	5 studies	25% ± 4%	Explore
lymph node	5 studies	21% ± 3%	Explore
liver	5 studies	36% ± 14%	Explore
bone marrow	4 studies	29% ± 10%	Explore
uterus	4 studies	28% ± 14%	Explore
breast	4 studies	22% ± 5%	Explore
adipose	4 studies	38% ± 16%	Explore
pancreas	3 studies	46% ± 10%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
breast	100%	7255.10	459 / 459	100%	48.42	1118 / 1118
prostate	100%	7161.54	245 / 245	100%	36.73	502 / 502
uterus	100%	7213.94	170 / 170	100%	38.19	459 / 459
esophagus	100%	6765.78	1444 / 1445	100%	46.90	183 / 183
bladder	100%	6911.19	21 / 21	100%	36.04	503 / 504
thymus	100%	8791.86	653 / 653	100%	40.13	603 / 605
lung	100%	6394.26	578 / 578	100%	34.33	1151 / 1155
stomach	100%	5632.92	359 / 359	100%	31.79	285 / 286
intestine	100%	6836.54	966 / 966	100%	31.65	525 / 527
pancreas	100%	3288.81	328 / 328	99%	35.22	177 / 178
brain	100%	4854.86	2641 / 2642	99%	36.13	701 / 705
kidney	100%	5697.44	89 / 89	99%	29.79	893 / 901
ovary	100%	6420.91	180 / 180	99%	21.14	425 / 430
skin	100%	7429.93	1809 / 1809	99%	33.84	466 / 472
liver	100%	3443.15	226 / 226	98%	19.70	398 / 406
adrenal gland	100%	4549.79	258 / 258	95%	24.50	218 / 230
adipose	100%	7041.80	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	41.41	29 / 29
muscle	100%	5289.98	803 / 803	0%	0	0 / 0
spleen	100%	8490.23	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	35.12	45 / 45
ureter	0%	0	0 / 0	100%	19.51	1 / 1
blood vessel	100%	5547.75	1334 / 1335	0%	0	0 / 0
heart	98%	3960.96	848 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	95%	20.76	76 / 80
peripheral blood	90%	4025.39	835 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

IV. Literature review

[source]

Gene name	SLTM
Protein name	SAFB like transcription modulator SAFB-like transcription modulator (Modulator of estrogen-induced transcription)
Synonyms	MET
Description	FUNCTION: When overexpressed, acts as a general inhibitor of transcription that eventually leads to apoptosis. .
Accessions	ENST00000559880.5 ENST00000558486.5 ENST00000249736.11 H0YNF3 Q9NWH9 H7BXE3 H0YLE6 H0YLW7 ENST00000432750.5 H7C3F4 H0YKU6 ENST00000559261.1 ENST00000559305.5 ENST00000560682.5 H0YL55 ENST00000628684.2 ENST00000557791.1 H0YKH2 H0YMM0 ENST00000380516.7 [Q9NWH9-1] ENST00000558756.5 H0YMR6 ENST00000560494.1 ENST00000557924.5 H0YMW8 ENST00000492526.5

GO_0050684	Biological process	regulation of mRNA processing
GO_0006915	Biological process	apoptotic process
GO_0006357	Biological process	regulation of transcription by RNA polymerase II
GO_0016604	Cellular component	nuclear body
GO_0005654	Cellular component	nucleoplasm
GO_0005634	Cellular component	nucleus
GO_0003723	Molecular function	RNA binding
GO_0005515	Molecular function	protein binding
GO_0043565	Molecular function	sequence-specific DNA binding

SLTM report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review